Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s goals for 2030
The weight-loss-drug manufacturer failed to excite investors hoping for a turnaround.
Similar Posts
Chain reaction: can the UK drive demand for digital gilts?
Chain reaction: can the UK drive demand for digital gilts? – Risk.net Skip to main content End of drawer navigation content Market will need regulatory clarity, fungibility with traditional issuance and interoperable protocols Among many questions facing new UK finance minister John Healey, reviving a troubled market for gilts is one of the most…
U.S. strikes Iran before Hormuz Strait blockade restarts
An F-35B Lighting II, attached to Marine Fighter Attack Squadron (VMFA) 121, takes off from the flight deck of America-class amphibious assault ship USS Tripoli (LHA 7), May 13, 2026. Courtesy: U.S. Navy U.S. forces launched strikes against Iranian targets shortly before the U.S. resumed its naval blockade of Iranian ports in and around the…
New Jersey Is On The Verge Of Becoming An Industrial Landlord’s Market
Declining deliveries and a steady stream of consumer demand for e-commerce are buoying New Jersey’s industrial market, despite supply constraints and regulatory hurdles. Industrial deliveries were down 58% year-over-year in New Jersey in the third quarter, resulting in heightened absorption figures, according to a Newmark report. And with high borrowing costs and local regulations likely…
Defiance Launches New Israel ETF ISRL
Defiance ETFs has launched a new strategy today, bringing the Defiance KSM Israel 120 (ISRL) ETF to the broader ETF marketplace. The strategy adds to the single nation segment of the overall ETF landscape, a useful toolset for ex-U.S. diversification or for making single nation bets. Key Takeaways: The new ISRL ETF launched today, tracking…
Senate cloture vote on Clarity Act fails, dealing regulatory blow to crypto industry
The Senate on Tuesday voted to block the Clarity Act from advancing, dealing a major blow to the crypto industry’s push for a comprehensive market structure framework. The procedural vote leaves the bill stalled on Capitol Hill after months of negotiations aimed at building bipartisan support. Republican leaders had released a revised version of the…
D-Wave’s Commercial Momentum Is Real, but a Critical Gap Remains
D-Wave (QBTS +0.86%) is showing real signs of commercial momentum as bookings, RPO, and production quantum usage climb. But revenue remains small and uneven, leaving investors with a crucial question: can growing QCaaS usage turn today’s customer commitments into the recurring business needed to support the stock’s valuation? Stock prices used were the market prices…
